10137- ML-3 HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (HDC-ASCT) FOR THE PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Neuro-Oncology Advances

Topics

Biology

Cancer Oncology

Medicine

Internal Medicine

Neurology

Show all topics

DOI

10.1093/noajnl/vdae173.073

License

CC-BY-NC